Diab Almhana, MD
Psychiatry · Avon Lake, OHNPI 1619053477
Payments from drug & device makers
Across 2,196 payments — averaging $1215.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.5M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$381K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$350K
- Acadia Pharmaceuticals Inc$134K
- Supernus Pharmaceuticals, Inc.$77K
- Sumitomo Pharma America, Inc.$49K
- plus $150K from 37 others
Across 23 payments — averaging $163.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
- AbbVie$1K
What the payments were for
- Consulting fees$10,9643%
- Speaking & faculty fees$377,21687%
- Travel & lodging$19,1224%
- Food & beverage$26,6046%
- Education$2080%
- Gifts$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,669,891 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 34 | $355,411 |
| CaplytaLumateperone Tosylate | 20 | $37,909 |
| AplenzinBupropion Hbr | 11 | $29,488 |
| TrintellixVortioxetine Hydrobromide | 24 | $19,817 |
| VraylarCariprazine Hcl | 12 | $17,946 |
| BelsomraSuvorexant | 21 | $8,758 |
| Aripiprazole | 44 | $2,038 |
| Lurasidone Hcl | 20 | $2,030 |
| Clonazepam | 141 | $1,907 |
| Duloxetine Hcl | 62 | $1,610 |
| Vilazodone Hcl | 11 | $1,527 |
| Alprazolam | 158 | $1,425 |
| Methylphenidate Hcl | 29 | $1,403 |
| Quetiapine Fumarate | 85 | $1,317 |
| Bupropion XlBupropion Hcl | 74 | $1,288 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $394 | $355,41134 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $349,928 | $37,90920 claims |
| Bausch Health US, LLCAplenzin | $982 | $29,48811 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $7,106 | $19,81724 claims |
| AbbVieVraylar | $1,527,947 | $17,94612 claims |
| MerckBelsomra | $312 | $8,75821 claims |
| Almatica Pharma LLCSertraline Hcl | $32 | $44265 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Avon Lake
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Otto DuenoDayton$3.1M
- Mohamed Abdel AzizWest Chester$2.6M
- Fred RomeoColumbus$2.3M
- Mark WoyshvilleMiddleburg Heights$2.2M
- Amita PatelDayton$2.1M
- Caleb AdlerCincinnati$2M
- Richard SandersDayton$1.8M
- Pradeep ManudhaneCanton$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.